Physician profile
Louis Conte
NPI 1952356651
$1,964.53
in general payments reported to CMS, 2019-2025
13 companies · $558 in 2025
The $558 reported for 2025 was more than what 78% of Plastic Surgery Within The Head & Neck providers received nationally (typical 2025 total: $238).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $234 · 2020: $14.47 · 2021: $260 · 2022: $358 · 2023: $419 · 2024: $122 · 2025: $558.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,099.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,098.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optinose US, INC. | $469.14 | 2019-2023 | |
| Glaxosmithkline, LLC. | $435.80 | 2022-2025 | Nucala |
| Regeneron Healthcare Solutions, INC. | $364.59 | 2021-2025 | Dupixent |
| Merz North America, INC. | $174.88 | 2019-2021 | |
| Alk-Abello, INC | $150.97 | 2019-2024 | Odactra, Ragwitek, Grastek |
| Genzyme Corporation | $120.08 | 2021-2025 | |
| Inspire Medical Systems, INC. | $76.29 | 2024-2025 | Inspire |
| Astrazeneca Pharmaceuticals Lp | $50.87 | 2025 | Tezspire |
| Stryker Corporation | $36.63 | 2019 | |
| Merck Sharp & Dohme LLC | $34.00 | 2023 | |
| Aerin Medical INC. | $21.47 | 2024 | |
| Ethicon US, LLC | $19.00 | 2025 | Ethicon, Stratafix |
| Novartis Pharmaceuticals Corporation | $10.81 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Louis Conte listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.